339 related articles for article (PubMed ID: 8411552)
1. Factors affecting late mortality from heart disease after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
JAMA; 1993 Oct; 270(16):1949-55. PubMed ID: 8411552
[TBL] [Abstract][Full Text] [Related]
2. Cardiac disease following treatment of Hodgkin's disease in children and adolescents.
Hancock SL; Donaldson SS; Hoppe RT
J Clin Oncol; 1993 Jul; 11(7):1208-15. PubMed ID: 8315419
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
4. Cardiac risk after mediastinal irradiation for Hodgkin's disease.
Glanzmann C; Kaufmann P; Jenni R; Hess OM; Huguenin P
Radiother Oncol; 1998 Jan; 46(1):51-62. PubMed ID: 9488128
[TBL] [Abstract][Full Text] [Related]
5. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
[TBL] [Abstract][Full Text] [Related]
6. Late valvular and other cardiac diseases after different doses of mediastinal radiotherapy for Hodgkin disease in children and adolescents: report from the longitudinal GPOH follow-up project of the German-Austrian DAL-HD studies.
Schellong G; Riepenhausen M; Bruch C; Kotthoff S; Vogt J; Bölling T; Dieckmann K; Pötter R; Heinecke A; Brämswig J; Dörffel W
Pediatr Blood Cancer; 2010 Dec; 55(6):1145-52. PubMed ID: 20734400
[TBL] [Abstract][Full Text] [Related]
7. [Combined-modality therapy for 150 cases of early-stage Hodgkin's lymphoma].
Niu Y; Shi YK; He XH; Feng FY; Zhou LQ; Gu DZ
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):630-4. PubMed ID: 19102946
[TBL] [Abstract][Full Text] [Related]
8. The risk of acute leukemia in patients treated for Hodgkin's disease is significantly higher aft [see bined modality programs than after chemotherapy alone and is correlated with the extent of radiotherapy and type and duration of chemotherapy: a case-control study.
Brusamolino E; Anselmo AP; Klersy C; Santoro M; Orlandi E; Pagnucco G; Lunghi F; Maurizi-Enrici R; Baroni CD; Lazzarino M; Mandelli F; Bernasconi C
Haematologica; 1998 Sep; 83(9):812-23. PubMed ID: 9825578
[TBL] [Abstract][Full Text] [Related]
9. Myocardial infarction mortality risk after treatment for Hodgkin disease: a collaborative British cohort study.
Swerdlow AJ; Higgins CD; Smith P; Cunningham D; Hancock BW; Horwich A; Hoskin PJ; Lister A; Radford JA; Rohatiner AZ; Linch DC
J Natl Cancer Inst; 2007 Feb; 99(3):206-14. PubMed ID: 17284715
[TBL] [Abstract][Full Text] [Related]
10. Increased mortality after successful treatment for Hodgkin's disease.
Hudson MM; Poquette CA; Lee J; Greenwald CA; Shah A; Luo X; Thompson EI; Wilimas JA; Kun LE; Crist WM
J Clin Oncol; 1998 Nov; 16(11):3592-600. PubMed ID: 9817280
[TBL] [Abstract][Full Text] [Related]
11. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
12. Coronary artery disease mortality in patients treated for Hodgkin's disease.
Boivin JF; Hutchison GB; Lubin JH; Mauch P
Cancer; 1992 Mar; 69(5):1241-7. PubMed ID: 1739922
[TBL] [Abstract][Full Text] [Related]
13. Screening for coronary artery disease after mediastinal irradiation for Hodgkin's disease.
Heidenreich PA; Schnittger I; Strauss HW; Vagelos RH; Lee BK; Mariscal CS; Tate DJ; Horning SJ; Hoppe RT; Hancock SL
J Clin Oncol; 2007 Jan; 25(1):43-9. PubMed ID: 17194904
[TBL] [Abstract][Full Text] [Related]
14. Hodgkin's disease: complications of therapy and excess mortality.
Hoppe RT
Ann Oncol; 1997; 8 Suppl 1():115-8. PubMed ID: 9187444
[TBL] [Abstract][Full Text] [Related]
15. Combined-modality therapy versus radiotherapy alone for treatment of early-stage Hodgkin's disease: cure balanced against complications.
Koontz BF; Kirkpatrick JP; Clough RW; Prosnitz RG; Gockerman JP; Moore JO; Prosnitz LR
J Clin Oncol; 2006 Feb; 24(4):605-11. PubMed ID: 16446333
[TBL] [Abstract][Full Text] [Related]
16. Thallium-201 scintigraphy is not predictive of late cardiac complications in patients with Hodgkin's disease treated with mediastinal radiation.
Girinsky T; Cordova A; Rey A; Cosset JM; Tertian G; Pierga JY
Int J Radiat Oncol Biol Phys; 2000 Dec; 48(5):1503-6. PubMed ID: 11121655
[TBL] [Abstract][Full Text] [Related]
17. Ischemic heart disease after mantlefield irradiation for Hodgkin's disease in long-term follow-up.
Reinders JG; Heijmen BJ; Olofsen-van Acht MJ; van Putten WL; Levendag PC
Radiother Oncol; 1999 Apr; 51(1):35-42. PubMed ID: 10386715
[TBL] [Abstract][Full Text] [Related]
18. Long-term events in adult patients with clinical stage IA-IIA nonbulky Hodgkin's lymphoma treated with four cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine and adjuvant radiotherapy: a single-institution 15-year follow-up.
Brusamolino E; Baio A; Orlandi E; Arcaini L; Passamonti F; Griva V; Casagrande W; Pascutto C; Franchini P; Lazzarino M
Clin Cancer Res; 2006 Nov; 12(21):6487-93. PubMed ID: 17085663
[TBL] [Abstract][Full Text] [Related]
19. Risk of second malignancy after Hodgkin's disease in a collaborative British cohort: the relation to age at treatment.
Swerdlow AJ; Barber JA; Hudson GV; Cunningham D; Gupta RK; Hancock BW; Horwich A; Lister TA; Linch DC
J Clin Oncol; 2000 Feb; 18(3):498-509. PubMed ID: 10653865
[TBL] [Abstract][Full Text] [Related]
20. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
Aisenberg AC; Finkelstein DM; Doppke KP; Koerner FC; Boivin JF; Willett CG
Cancer; 1997 Mar; 79(6):1203-10. PubMed ID: 9070499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]